Skip to main content
Erschienen in: World Journal of Surgery 7/2011

01.07.2011

Surgical Outcome for Mycotic Aortic and Iliac Anuerysm

verfasst von: Sheng-Yueh Yu, Hung-Chang Hsieh, Po-Jen Ko, Yao-Kuang Huang, Jaw-Ji Chu, Chun-Hui Lee

Erschienen in: World Journal of Surgery | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

The present study was designed to review surgical outcomes for mycotic aneurysm of the aortic or iliac arteries at a single center.

Methods

The study was based on retrospective chart review of patients undergoing operation for mycotic aneurysm.

Results

From January 1998 to December 2007, 56 patients received surgical treatment for mycotic aneurysm of the aortic or iliac arteries. Aneurysm sites included the aortic arch (n = 5), proximal thoracic aorta (n = 4), distal thoracic aorta (n = 5), paravisceral aorta (n = 5), juxtarenal aorta (n = 4), infrarenal aorta (n = 30), and iliac arteries (n = 3). Salmonella was the leading pathogen (n = 34). Nineteen patients with suprarenal lesions underwent in situ prosthetic graft replacement (n = 17), extra-anatomic bypass (n = 1), or endovascular aneurysm repair (EVAR) (n = 1), and 37 patients with infrarenal lesions underwent the same procedures (n = 16, 20, and 1, respectively). Overall in-hospital mortality was 23%. After discharge, four patients (7%) developed reinfection that led to fatal sepsis. Graft infection developed after three in situ prosthetic grafts (9%) and one extra-anatomic bypass (5%). Patients with suprarenal aortic lesions had poorer in-hospital (34%) and late (16%) mortality rates than those with infrarenal lesions (p = 0.025). Those with suprarenal lesions also had a lower cumulative survival rate (p = 0.016).

Conclusions

The location of mycotic aneurysm was the determinant of mortality. Mycotic aneurysm of the suprarenal aorta has poor prognosis and requires alternative surgical treatment.
Literatur
1.
Zurück zum Zitat Brown SL, Busuttil RW, Baker JD et al (1984) Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg 1:541–547PubMedCrossRef Brown SL, Busuttil RW, Baker JD et al (1984) Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg 1:541–547PubMedCrossRef
2.
Zurück zum Zitat Wang JH, Liu YC, Yen MY et al (1996) Mycotic aneurysm due to non-typhi salmonella: report of 16 cases. Clin Infect Dis 23:743–747PubMedCrossRef Wang JH, Liu YC, Yen MY et al (1996) Mycotic aneurysm due to non-typhi salmonella: report of 16 cases. Clin Infect Dis 23:743–747PubMedCrossRef
3.
Zurück zum Zitat Muller BT, Wegener OR, Grabitz K et al (2001) Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg 33:106–113PubMedCrossRef Muller BT, Wegener OR, Grabitz K et al (2001) Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg 33:106–113PubMedCrossRef
4.
Zurück zum Zitat Oderich GS, Panneton JM, Bower TC et al (2001) Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. J Vasc Surg 34:900–908PubMedCrossRef Oderich GS, Panneton JM, Bower TC et al (2001) Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. J Vasc Surg 34:900–908PubMedCrossRef
5.
Zurück zum Zitat Hsu R-B, Tsay Y-G, Wang S-S et al (2002) Surgical treatment for primary infected aneurysm of the descending thoracic aorta, abdominal aorta, and iliac arteries. J Vasc Surg 36:746–750PubMedCrossRef Hsu R-B, Tsay Y-G, Wang S-S et al (2002) Surgical treatment for primary infected aneurysm of the descending thoracic aorta, abdominal aorta, and iliac arteries. J Vasc Surg 36:746–750PubMedCrossRef
6.
Zurück zum Zitat Luo C-Y, Ko W-C, Kan C-D et al (2003) In situ reconstruction of septic aortic pseudoaneurysm due to Salmonella or Streptococcus microbial aortitis: long-term follow-up. J Vasc Surg 38:975–982PubMedCrossRef Luo C-Y, Ko W-C, Kan C-D et al (2003) In situ reconstruction of septic aortic pseudoaneurysm due to Salmonella or Streptococcus microbial aortitis: long-term follow-up. J Vasc Surg 38:975–982PubMedCrossRef
7.
Zurück zum Zitat Kyriakides C, Kan Y, Kerle M et al (2004) 11-year experience with anatomical and extra-anatomical repair of mycotic aortic aneurysms. Eur J Vasc Endovasc Surg 27:585–589PubMedCrossRef Kyriakides C, Kan Y, Kerle M et al (2004) 11-year experience with anatomical and extra-anatomical repair of mycotic aortic aneurysms. Eur J Vasc Endovasc Surg 27:585–589PubMedCrossRef
8.
Zurück zum Zitat Ting AC, Cheng SW, Ho P et al (2005) Surgical treatment of infected aneurysms and pseudoaneurysms of the thoracic and abdominal aorta. Am J Surg 189:150–154PubMedCrossRef Ting AC, Cheng SW, Ho P et al (2005) Surgical treatment of infected aneurysms and pseudoaneurysms of the thoracic and abdominal aorta. Am J Surg 189:150–154PubMedCrossRef
9.
Zurück zum Zitat Woon CYL, Sebastian MG, Tay K-H et al (2008) Extra-anatomic revascularization and aortic exclusion for mycotic aneurysms of the infrarenal aorta and iliac arteries in an Asian population. Am J Surg 195:66–72PubMedCrossRef Woon CYL, Sebastian MG, Tay K-H et al (2008) Extra-anatomic revascularization and aortic exclusion for mycotic aneurysms of the infrarenal aorta and iliac arteries in an Asian population. Am J Surg 195:66–72PubMedCrossRef
10.
Zurück zum Zitat Dubois M, Daenens K, Houthoofd S et al (2010) Treatment of mycotic aneurysms with involvement of the abdominal aorta: single-centre experience in 44 consecutive cases. Eur J Vasc Endovasc Surg 40:450–456PubMedCrossRef Dubois M, Daenens K, Houthoofd S et al (2010) Treatment of mycotic aneurysms with involvement of the abdominal aorta: single-centre experience in 44 consecutive cases. Eur J Vasc Endovasc Surg 40:450–456PubMedCrossRef
12.
Zurück zum Zitat Hsu RB, Chen RJ, Wang SS et al (2004) Infected aortic aneurysms: clinical outcome and risk factor analysis. J Vasc Surg 40:30–35PubMedCrossRef Hsu RB, Chen RJ, Wang SS et al (2004) Infected aortic aneurysms: clinical outcome and risk factor analysis. J Vasc Surg 40:30–35PubMedCrossRef
13.
Zurück zum Zitat Taylor LM Jr, Deitz DM, McConnell DB et al (1988) Treatment of infected abdominal aneurysms by extraanatomic bypass, aneurysm excision, and drainage. Am J Surg 155:655–658PubMedCrossRef Taylor LM Jr, Deitz DM, McConnell DB et al (1988) Treatment of infected abdominal aneurysms by extraanatomic bypass, aneurysm excision, and drainage. Am J Surg 155:655–658PubMedCrossRef
14.
Zurück zum Zitat Soravia-Dunand VA, Loo VG, Salit IE (1999) Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature. Clin Infect Dis 29:862–868PubMedCrossRef Soravia-Dunand VA, Loo VG, Salit IE (1999) Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature. Clin Infect Dis 29:862–868PubMedCrossRef
15.
Zurück zum Zitat Johansen K, Devin J (1983) Mycotic aortic aneurysms. A reappraisal. Arch Surg 118:583–588PubMed Johansen K, Devin J (1983) Mycotic aortic aneurysms. A reappraisal. Arch Surg 118:583–588PubMed
16.
Zurück zum Zitat Sessa C, Farah I, Voirin L et al (1997) Infected aneurysms of the infrarenal abdominal aorta: diagnostic criteria and therapeutic strategy. Ann Vasc Surg 11:453–463PubMedCrossRef Sessa C, Farah I, Voirin L et al (1997) Infected aneurysms of the infrarenal abdominal aorta: diagnostic criteria and therapeutic strategy. Ann Vasc Surg 11:453–463PubMedCrossRef
17.
Zurück zum Zitat Jarrett F, Darling RC, Mundth ED et al (1975) Experience with infected aneurysms of the abdominal aorta. Arch Surg 110:1281–1286PubMed Jarrett F, Darling RC, Mundth ED et al (1975) Experience with infected aneurysms of the abdominal aorta. Arch Surg 110:1281–1286PubMed
18.
Zurück zum Zitat Fernandez Guerrero ML, Aguado JM, Arribas A et al (2004) The spectrum of cardiovascular infections due to Salmonella enterica: a review of clinical features and factors determining outcome. Medicine (Baltimore) 83:123–138CrossRef Fernandez Guerrero ML, Aguado JM, Arribas A et al (2004) The spectrum of cardiovascular infections due to Salmonella enterica: a review of clinical features and factors determining outcome. Medicine (Baltimore) 83:123–138CrossRef
19.
Zurück zum Zitat Hsu RB, Lin FY (2005) Risk factors for bacteraemia and endovascular infection due to non-typhoid salmonella: a reappraisal. QJM 98:821–827PubMedCrossRef Hsu RB, Lin FY (2005) Risk factors for bacteraemia and endovascular infection due to non-typhoid salmonella: a reappraisal. QJM 98:821–827PubMedCrossRef
20.
Zurück zum Zitat Zhou W, Lin PH, Bush RL et al (2006) In situ reconstruction with cryopreserved arterial allografts for management of mycotic aneurysms or aortic prosthetic graft infections: a multi-institutional experience. Tex Heart Inst J 33:14–18PubMed Zhou W, Lin PH, Bush RL et al (2006) In situ reconstruction with cryopreserved arterial allografts for management of mycotic aneurysms or aortic prosthetic graft infections: a multi-institutional experience. Tex Heart Inst J 33:14–18PubMed
21.
Zurück zum Zitat Brown KE, Heyer K, Rodriguez H et al (2009) Arterial reconstruction with cryopreserved human allografts in the setting of infection: a single-center experience with midterm follow-up. J Vasc Surg 49:660–666PubMedCrossRef Brown KE, Heyer K, Rodriguez H et al (2009) Arterial reconstruction with cryopreserved human allografts in the setting of infection: a single-center experience with midterm follow-up. J Vasc Surg 49:660–666PubMedCrossRef
22.
Zurück zum Zitat Benjamin ME, Cohn EJ Jr, Purtill WA et al (1999) Arterial reconstruction with deep leg veins for the treatment of mycotic aneurysms. J Vasc Surg 30:1004–1015PubMedCrossRef Benjamin ME, Cohn EJ Jr, Purtill WA et al (1999) Arterial reconstruction with deep leg veins for the treatment of mycotic aneurysms. J Vasc Surg 30:1004–1015PubMedCrossRef
23.
Zurück zum Zitat Ehsan O, Gibbons CP (2009) A 10-year experience of using femoro-popliteal vein for re-vascularisation in graft and arterial infections. Eur J Vasc Endovasc Surg 38:172–179PubMedCrossRef Ehsan O, Gibbons CP (2009) A 10-year experience of using femoro-popliteal vein for re-vascularisation in graft and arterial infections. Eur J Vasc Endovasc Surg 38:172–179PubMedCrossRef
24.
Zurück zum Zitat Hsu RB, Tsay YG, Wang SS et al (2003) Management of aortic aneurysm infected with Salmonella. Br J Surg 90:1080–1084PubMedCrossRef Hsu RB, Tsay YG, Wang SS et al (2003) Management of aortic aneurysm infected with Salmonella. Br J Surg 90:1080–1084PubMedCrossRef
25.
Zurück zum Zitat Hsu R-B, Lin F-Y (2007) Surgery for infected aneurysm of the aortic arch. J Thorac Cardiovasc Surg 134:1157–1162PubMedCrossRef Hsu R-B, Lin F-Y (2007) Surgery for infected aneurysm of the aortic arch. J Thorac Cardiovasc Surg 134:1157–1162PubMedCrossRef
26.
27.
Zurück zum Zitat Fillmore AJ, Valentine RJ (2003) Surgical mortality in patients with infected aortic aneurysms. J Am Coll Surg 196:435–441PubMedCrossRef Fillmore AJ, Valentine RJ (2003) Surgical mortality in patients with infected aortic aneurysms. J Am Coll Surg 196:435–441PubMedCrossRef
28.
Zurück zum Zitat Ihaya A, Chiba Y, Kimura T et al (2001) Surgical outcome of infectious aneurysm of the abdominal aorta with or without SIRS. Cardiovasc Surg 9:436–440PubMedCrossRef Ihaya A, Chiba Y, Kimura T et al (2001) Surgical outcome of infectious aneurysm of the abdominal aorta with or without SIRS. Cardiovasc Surg 9:436–440PubMedCrossRef
29.
Zurück zum Zitat Greenhalgh RM, Brown LC, Kwong GP et al (2004) Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet 364:843–848PubMedCrossRef Greenhalgh RM, Brown LC, Kwong GP et al (2004) Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet 364:843–848PubMedCrossRef
30.
Zurück zum Zitat Matsumura JS, Cambria RP, Dake MD et al (2008) International controlled clinical trial of thoracic endovascular aneurysm repair with the Zenith TX2 endovascular graft: 1-year results. J Vasc Surg 47:247–257 (discussion 257)PubMedCrossRef Matsumura JS, Cambria RP, Dake MD et al (2008) International controlled clinical trial of thoracic endovascular aneurysm repair with the Zenith TX2 endovascular graft: 1-year results. J Vasc Surg 47:247–257 (discussion 257)PubMedCrossRef
31.
Zurück zum Zitat Kan CD, Lee HL, Yang YJ (2007) Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review. J Vasc Surg 46:906–912PubMedCrossRef Kan CD, Lee HL, Yang YJ (2007) Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review. J Vasc Surg 46:906–912PubMedCrossRef
32.
Zurück zum Zitat Razavi MK, Razavi MD (2008) Stent-graft treatment of mycotic aneurysms: a review of the current literature. J Vasc Interv Radiol 19:S51–S56PubMedCrossRef Razavi MK, Razavi MD (2008) Stent-graft treatment of mycotic aneurysms: a review of the current literature. J Vasc Interv Radiol 19:S51–S56PubMedCrossRef
33.
Zurück zum Zitat Clough RE, Black SA, Lyons OT et al (2009) Is endovascular repair of mycotic aortic aneurysms a durable treatment option? Eur J Vasc Endovasc Surg 37:407–412PubMedCrossRef Clough RE, Black SA, Lyons OT et al (2009) Is endovascular repair of mycotic aortic aneurysms a durable treatment option? Eur J Vasc Endovasc Surg 37:407–412PubMedCrossRef
34.
Zurück zum Zitat Sorelius K, Mani K, Bjorck M et al (2009) Endovascular repair of mycotic aortic aneurysms. J Vasc Surg 50:269–274PubMedCrossRef Sorelius K, Mani K, Bjorck M et al (2009) Endovascular repair of mycotic aortic aneurysms. J Vasc Surg 50:269–274PubMedCrossRef
Metadaten
Titel
Surgical Outcome for Mycotic Aortic and Iliac Anuerysm
verfasst von
Sheng-Yueh Yu
Hung-Chang Hsieh
Po-Jen Ko
Yao-Kuang Huang
Jaw-Ji Chu
Chun-Hui Lee
Publikationsdatum
01.07.2011
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 7/2011
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1104-9

Weitere Artikel der Ausgabe 7/2011

World Journal of Surgery 7/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.